Enveric Biosciences (ENVB) Revenue (2014 - 2020)
Enveric Biosciences (ENVB) posted Revenue of $8.48 million for Q3 2020, down 7.3% from $9.15 million a year earlier but up 2.8% from the prior quarter.
Enveric Biosciences (ENVB) Revenue (2014 - 2020) Analysis & Trends
For the trailing twelve months through Sep 30, 2020, Revenue at Enveric Biosciences was $35.41 million, down 13.9% year-over-year; for FY2019, it was $39.91 million, down 7.2% from FY2018.
- Annual Revenue shows a four-year compound annual growth rate of 18.5% (FY2015 to FY2019).
- In prior years, Enveric Biosciences' Revenue was $43 million in FY2018 (-11.5%), $48.59 million in FY2017 (+34.4%), $36.15 million in FY2016 (+78.4%) and $20.26 million in FY2015.
- Quarterly Revenue has run from a low of $6.69 million in Q2 2016 to a high of $12.53 million in Q3 2017 over five years.
- On a year-over-year basis, Revenue has declined in each of the last 12 quarters, with an average decline of 10.3% over the last eight quarters.
- The strongest year-over-year quarter for Revenue in the past five years was Q3 2016, with growth of 125.4%; the weakest was Q2 2020, with a decline of 25.1%.
- According to Business Quant data, Revenue for the three prior quarters was $8.25 million (Q2 2020), $9.6 million (Q1 2020) and $9.06 million (Q4 2019).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Enveric Biosciences | 5.86 Mn | -15.78 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 8.48 Mn |
| Jun 30, 2020 | 8.25 Mn |
| Mar 31, 2020 | 9.60 Mn |
| Dec 31, 2019 | 9.06 Mn |
| Sep 30, 2019 | 9.15 Mn |
| Jun 30, 2019 | 11.02 Mn |
| Mar 31, 2019 | 10.69 Mn |
| Dec 31, 2018 | 10.28 Mn |
| Sep 30, 2018 | 10.58 Mn |
| Jun 30, 2018 | 11.08 Mn |
| Mar 31, 2018 | 11.06 Mn |
| Dec 31, 2017 | 11.45 Mn |
| Sep 30, 2017 | 12.53 Mn |
| Jun 30, 2017 | 12.27 Mn |
| Mar 31, 2017 | 12.34 Mn |
| Dec 31, 2016 | 12.39 Mn |
| Sep 30, 2016 | 10.06 Mn |
| Jun 30, 2016 | 6.69 Mn |
| Mar 31, 2016 | 7.01 Mn |
| Dec 31, 2015 | 7.58 Mn |
Enveric Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=ENVB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "ENVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=ENVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();